Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COLLEGIUM PHARMACEUTICAL, INC.

(COLL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 571690693631631-
Enterprise Value (EV)1 436531776631631631
P/E ratio -14,4x-30,3x26,4x6,46x10,6x9,01x
Yield ------
Capitalization / Revenue 2,04x2,33x2,23x1,90x1,83x1,68x
EV / Revenue 2,04x2,33x2,23x1,90x1,83x1,68x
EV / EBITDA -58,3x91,6x4,96x3,82x3,55x3,17x
Price to Book ------
Nbr of stocks (in thousands) 33 24733 52734 58234 79734 797-
Reference price (USD) 17,220,620,018,118,118,1
Announcement Date 02/27/201902/27/202002/25/2021---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 280297310331345376
EBITDA1 -9,797,53140165178199
Operating profit (EBIT)1 -20,7-23,756,271,182,493,8
Operating Margin -7,38%-8,00%18,1%21,4%23,9%25,0%
Pre-Tax Profit (EBT)1 -39,1-22,727,648,967,584,8
Net income1 -39,1-22,726,810961,875,8
Net margin -14,0%-7,66%8,63%33,0%17,9%20,2%
EPS2 -1,19-0,680,762,811,712,01
Dividend per Share ------
Announcement Date 02/27/201902/27/202002/25/2021---
1 USD in Million
2 USD
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 87,782,978,881,882,887,0
EBITDA1 45,340,137,342,141,044,7
Operating profit (EBIT)1 21,216,414,119,3--
Operating Margin 24,2%19,8%17,9%23,6%--
Pre-Tax Profit (EBT)1 15,511,09,0413,4--
Net income1 15,772,88,0512,9--
Net margin 17,9%87,8%10,2%15,8%--
EPS2 0,411,790,220,36--
Dividend per Share ------
Announcement Date 05/06/202108/05/202111/04/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt --83,0---
Net Cash position 135159----
Leverage (Debt / EBITDA) 13,8x-21,0x0,59x---
Free Cash Flow -21,3--181153
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 5,486,445,553,253,253,25
Capex / Sales 1,95%2,17%1,79%0,98%0,94%0,86%
Announcement Date 02/27/201902/27/202002/25/2021---
1 USD in Million
Previous periodNext period
Key data
Capitalization (USD) 630 524 412
Net sales (USD) 310 016 000
Number of employees 234
Sales / Employee (USD) 1 324 855
Free-Float 96,3%
Free-Float capitalization (USD) 606 881 092
Avg. Exchange 20 sessions (USD) 3 665 703
Average Daily Capital Traded 0,58%
EPS & Dividend
Year-on-year evolution of the PER